why choose us

First received: November 15, 2024

Clinical Trial: A Study to Test How Zongertinib is Taken up in the Blood of People With and Without Liver Problems

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Liver Diseases

Study Type: INTERVENTIONAL


Official Title: Pharmacokinetics, Safety and Tolerability of Zongertinib Following Oral Administration in Male and Female Participants of Non-childbearing Potential With Different Degrees of Hepatic Impairment (Child

Brief Summary: This study is open to adults between 18 and 80 years of age.People with a body mass index (BMI) between 18 and 42 kg/m^2 can take part.Women can only participate if they cannot get pregnant.This study includes people with mild liver problems, people with moderate liver problems, and people without liver problems as a matching control.The purpose of this study is to find out how mild and moderate liver problems affect how the body handles a medicine called zongertinib.Participants take zongertinib once as…

Read more